0001104659-23-063347.txt : 20230523 0001104659-23-063347.hdr.sgml : 20230523 20230523060801 ACCESSION NUMBER: 0001104659-23-063347 CONFORMED SUBMISSION TYPE: RW PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20230523 DATE AS OF CHANGE: 20230523 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Aesthetic Medical International Holdings Group Ltd CENTRAL INDEX KEY: 0001757143 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-SPECIALTY OUTPATIENT FACILITIES, NEC [8093] IRS NUMBER: 000000000 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: RW SEC ACT: SEC FILE NUMBER: 333-265667 FILM NUMBER: 23946452 BUSINESS ADDRESS: STREET 1: 4068 QIAOXIANG ROAD STREET 2: NANSHAN DISTRICT CITY: SHENZHEN STATE: F4 ZIP: 518053 BUSINESS PHONE: 917 609-0333 MAIL ADDRESS: STREET 1: 4068 QIAOXIANG ROAD STREET 2: NANSHAN DISTRICT CITY: SHENZHEN STATE: F4 ZIP: 518053 RW 1 tm2316539d1_rw.htm RW

Aesthetic Medical International Holdings Group Limited

1122 Nanshan Boulevard,

Nanshan District, Shenzhen,

Guangdong Province 518052

The People’s Republic of China

May 23, 2023

VIA EDGAR

Division of Corporation Finance

Securities and Exchange Commission

100 F Street NE

Washington, D.C. 20549

Re:

Aesthetic Medical International Holdings Group Limited

Registration Statement on Form F-3 (File No. 333-265667)

Request for Withdrawal

Dear Sirs:

Pursuant to Rule 477 promulgated under the Securities Act of 1933, as amended, Aesthetic Medical International Holdings Group Limited (the “Company”) hereby respectfully requests that the Securities and Exchange Commission (the “Commission”) consent to the withdrawal of the Company’s Registration Statement on Form F-3 (File No. 333-265667), together with all exhibits thereto (the “Registration Statement”). The Company has determined not to proceed at this time with the offering and sale of the securities proposed to be covered by the Registration Statement.

The Company confirms that the Registration Statement has not been declared effective and no securities have been or will be issued or sold pursuant to the Registration Statement or the prospectus contained therein. The Company requests that the Commission consent to this request on grounds that the withdrawal of the Registration Statement is consistent with the public interest and protection of investors, as contemplated by paragraph (a) of Rule 477 under the Securities Act.

The Company further requests that, in accordance with Rule 457(p) under the Securities Act, all fees paid to the Commission in connection with the filing of the Registration Statement be credited to the Company’s account to be offset against the filing fee for any future registration statement of the Company or an affiliate of the Company.

Pursuant to the requirements of Rule 477 under the Securities Act, the Company has duly caused this request for withdrawal to be signed on its behalf by the undersigned, thereunto duly authorized.

	Sincerely,

	Aesthetic Medical International Holdings Group Limited

	/s/ Wu Guanhua
	Name: Wu Guanhua
	Title: Chief Financial Officer